Insilico’s AI-built pill cuts colitis scores by 60% in animal tests
Insilico Medicine nominates ISM9546, an oral VAV1 degrader designed with generative AI, as a preclinical candidate for autoimmune disease. Some proteins have a reputation for being impossible to hit with a drug. VAV1 is one of them, and Insilico Medicine says an AI-designed pill has now taken a dece
<p>Insilico Medicine nominates ISM9546, an oral VAV1 degrader designed with generative AI, as a preclinical candidate for autoimmune disease. Some proteins have a reputation for being impossible to hit with a drug. VAV1 is one of them, and Insilico Medicine says an AI-designed pill has now taken a dece</p>